Atkinson, NH, United States of America

Jill Ann Kublbeck


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Jill Ann Kublbeck**

Introduction

Jill Ann Kublbeck, an inventive mind from Atkinson, New Hampshire, has made significant strides in the realm of biotechnology. With a total of three patents to her name, she is renowned for her innovative techniques that enhance the manufacturing process of proteins while ensuring virus safety.

Latest Patents

Jill's most recent patent focuses on "Methods for continuously inactivating a virus during the manufacture of a protein." This groundbreaking method outlines several critical steps: firstly, it involves combining a composition that includes the protein and a composition containing a virus-inactivation reagent at a single predetermined volumetric ratio. This step ensures that the treatment composition possesses the required properties for effective virus inactivation. Secondly, the treatment composition is transferred to a treatment vessel for incubation under specific conditions. Finally, the composition undergoes post-treatment processing operations. The innovative aspect of her method lies in its continuous execution without feedback control adjustments, maintaining the property of the treatment composition across varying concentrations.

Career Highlights

Jill Kublbeck's career has been closely associated with Boehringer Ingelheim International GmbH, where her work has greatly influenced protein manufacturing processes. Her expertise not only contributes to the advancement of biotechnological innovations, but also ensures high safety standards in pharmaceutical manufacturing.

Collaborations

Throughout her career, Jill has had the privilege of working alongside esteemed colleagues, including Marcus Andre Fiadeiro and Jonathan Coffman. These collaborations have fostered a productive environment that encourages groundbreaking research and development in the field of biotechnology.

Conclusion

With a focus on innovative solutions for virus inactivation during protein manufacture, Jill Ann Kublbeck continues to push the boundaries of biotechnology. Her contributions exemplify the impact that inventors can have in advancing safety and efficiency in critical manufacturing processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…